Merck Animal Health

What Merck Animal Health does

Merck Animal Health is a division of Merck & Co., Inc. (NYSE: MRK) and operates as one of the largest global animal health companies, with a portfolio spanning veterinary pharmaceuticals, biologics, vaccines, parasiticides, reproductive hormones, animal identification systems (ALLFLEX), cattle monitoring technology (SenseHub), virtual fencing (Vence), and poultry biodevices (WingScan). It serves two principal customer sets: production animal operators (beef and dairy cattle, poultry, swine, goats, aquaculture, equine producers) requiring disease prevention, reproductive management, parasite control, and labor-saving monitoring; and companion animal owners served through licensed veterinarians with dermatology (NUMELVI, BRAVECTO), vaccines (NOBIVAC), parasiticide, and chronic-care products. The technical stack integrates proprietary vaccine platforms (NOBIVAC NXT RNA-particle technology), extended-release parasiticide formulations, sensor-based herd monitoring, GPS-enabled virtual fencing, and vision-based poultry processing, increasingly unified through a Salesforce Agentforce Life Sciences CRM platform consolidating data from devices, microchips, and prescription history.

The business model is predominantly one-time veterinary product sales priced through distributor and clinic markups, with growing subscription/recurring revenue from monitoring software (SenseHub, Vence) and device-based poultry technology (WingScan). Distribution is multi-tiered: seven national veterinary distributors plus regional distributors reach independent veterinarians and producers; dedicated field sales and technical services teams cover livestock, companion animal, and equine segments; and direct-to-consumer online purchasing is being piloted through Vetcove. Geographic reach spans 60+ countries with country-specific operations and dual branding as Merck Animal Health in North America and MSD Animal Health internationally.

Recent strategic activity is heavy on offensive moves: the $1.3 billion Elanco aqua business acquisition (February 2024) and pending TARGAN poultry biodevice acquisition (announced June 2026, expected close Q3 2026) extend the portfolio into adjacent species and industrial automation. Multiple FDA approvals have launched in quick succession: BRAVECTO QUANTUM as the only 12-month injectable parasiticide (July 2025), EXZOLT CATTLE-CA1 as the first novel beef cattle ectoparasiticide in decades (December 2025), NUMELVI as the first second-generation JAK inhibitor for canine pruritus (February 2026), and a BRAVECTO QUANTUM label expansion (March 2026). A strategic R&D collaboration with Rejuvenate Bio adds gene therapy for companion animals, and a Salesforce partnership modernizes the customer data platform. A new manufacturing facility in De Soto, Kansas adds capacity to support continued geographic and product-line expansion.

Name

Merck Animal Health

Legal name

Merck & Co., Inc.

Website

http://www.merck-animal-health-usa.com

Company type

Public

Founded year

1921

Operating status

Operating

Headcount range

11–50 employees

Short description

Merck Animal Health, a division of Merck & Co. (NYSE: MRK), is a global animal health company developing and marketing veterinary pharmaceuticals, vaccines, parasiticides, monitoring technology, and biodevices for production animals and companion animals across 60+ countries.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals and Animal Health

NAICS

Veterinary Services (54194)

SIC

Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Veterinary Vaccines (Biologics) (HLAMAEAL)

akta.pro secondary industries

Livestock Vaccines (Cattle, Swine, Sheep & Goats) (HLAMAKAB), Livestock & Farm Animal Veterinary Services (AFAEANAB)

Keywords

• Veterinary pharmaceuticals
• Animal vaccines
• Livestock monitoring technology
• Companion animal health
• Parasiticide products

Headquarters

HQ city

Summit

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Veterinary Pharmaceuticals & Biologics: Development, manufacture and marketing of a broad range of veterinary medicines including vaccines, parasiticides, anti-infectives, therapeutics, and reproductive hormones for all major farm and companion animal species. Products sold through distributors, veterinarians, and direct-to-pet-owner channels.
2. Animal Identification & Monitoring Technology: ALLFLEX livestock identification products and SenseHub cattle monitoring technology sold as hardware-tag products with associated software subscriptions. Vence virtual fencing system sold as GPS collar hardware with cloud-based software access.
3. Poultry Biodevice Technology: WingScan automated chick sexing and sorting technology, and precision ocular spray vaccine delivery systems sold as biodevice equipment to commercial poultry operations, with potential for device-based solutions integrated with existing vaccine portfolio.
4. Technology & Data Services: Agentforce Life Sciences platform providing unified customer data, self-service, intelligent sales, and personalized marketing capabilities to Merck Animal Health's customer engagement operations.

Pricing tiers

Go-to-market motion3 records

Distribution channels6 records

Marketing channels8 records

Core offering

Merck Animal Health develops, manufactures, and markets a broad portfolio of veterinary medicines including vaccines, parasiticides, anti-infectives, reproductive hormones, and biologics for companion animals (dogs, cats, horses) and production animals (cattle, swine, poultry, goats, aquaculture). The company also sells digital animal health technologies including ALLFLEX livestock identification, SenseHub cattle monitoring, Vence GPS virtual fencing, and (via the pending TARGAN acquisition) WingScan poultry vision-based chick processing.

Product overview

Merck Animal Health offers a broad portfolio of veterinary medicines, vaccines, parasiticides, anti-infectives, reproductive health products, feed additives, and digital health technologies across companion animals (dogs, cats, horses) and production animals (cattle, poultry, swine, goats, aquaculture). The portfolio is organized around major brand platforms including BRAVECTO (parasiticides), BOVILIS/NOBIVAC/INNOVAX (vaccines), SENSEHUB/VENCE/ALLFLEX (monitoring technology), SAFE-GUARD (dewormers), and reproductive products (ESTRUMATE/FERTAGYL). Recent product launches include NUMELVI (first second-generation JAK inhibitor for canine pruritus) and BRAVECTO QUANTUM (12-month injectable flea/tick protection), with strategic acquisitions including TARGAN (poultry biodevice technology with WingScan vision sorting).

Differentiator

Problem solved

Functional benefit

Brands

• ALLFLEX: Livestock identification and monitoring technology including ear tags, readers, and data management systems
• BRAVECTO
• BOVILIS
• EXZOLT
• INNOVAX
• NOBIVAC
• NUMELVI
• PRESTIGE
• SAFE-GUARD
• SENSEHUB
• SENTINEL
• SEQUIVITY
• VENCE
• VETSULIN
• VISION
• FERTAGYL
• ESTRUMATE
• CIRCUMVENT CL
• REVALOR
• RESFLOR GOLD
• COCCIVAC
• NASALGEN
• COVEXIN
• AQUAFLOR
• BIOMARK

Products and services

• BRAVECTO QUANTUM Extended-release injectable parasiticide providing 12 months of flea and tick protection in dogs with a single veterinarian-administered injection; fluralaner-based; expanded March 2026 label includes Asian longhorned tick and Gulf Coast tick.
• NUMELVI (atinvicitinib tablets) First and only second-generation JAK inhibitor selective for JAK1 approved for controlling pruritus associated with allergic dermatitis in dogs 6 months and older; once-daily oral tablet providing itch relief within 2-4 hours.
• EXZOLT CATTLE-CA1 Fluralaner topical solution for beef cattle for the prevention and treatment of New World screwworm infestations and treatment of cattle fever tick; first novel ectoparasiticide for beef cattle in decades.
• BOVILIS Cattle Vaccines Comprehensive cattle vaccine portfolio including INNOVAX, VISTA, NASALGEN, VISION, and COVEXIN lines covering BRD, clostridial diseases, reproductive diseases, and intranasal vaccines for beef and dairy operations.
• NOBIVAC Companion Animal Vaccines Companion animal vaccine platform including NOBIVAC NXT with RNA-particle technology covering rabies, canine distemper, parvovirus, and feline diseases including FeLV.
• TARGAN WingScan Poultry Biodevice Automated poultry biodevice using vision systems to identify and sort chicks by gender at up to 160,000 chicks per hour, with high-speed precision ocular spray technology for vaccine delivery to day-old chicks.
• SENSEHUB Cattle Monitoring Livestock monitoring platform using GPS and sensor-equipped ear tags tracking body temperature, activity levels, and health alerts for breeding, dairy youngstock, feedlot, and cow-calf operations.
• VENCE Virtual Fencing GPS-enabled collar system allowing ranchers to manage cattle movement and grazing patterns without traditional fencing, using cloud-based software control; deployed across US, Australia, and pilot programs in New Zealand and Canada.
• ALLFLEX Livestock Identification Livestock identification and monitoring technology including electronic ear tags, RFID systems, tissue sampling devices, and related applicators for cattle tracking and management.
• SAFE-GUARD Dewormers Fenbendazole-based dewormer portfolio for cattle, goats, horses, swine, poultry, and canines; available in paste, suspension, pellets, blocks, and medicated feed formulations.
• ESTRUMATE (cloprostenol) Prostaglandin-based reproductive hormone for heat synchronization, treatment of pyometra, chronic endometritis, luteal cysts, and termination of unwanted pregnancies in dairy and beef cattle; the #1 cloprostenol on the market.
• FERTAGYL (gonadorelin) GnRH (gonadotropin-releasing hormone) for reproductive management in beef cattle; used with ESTRUMATE in FTAI (fixed-time artificial insemination) programs.
• INNOVAX Poultry Vaccines Poultry vaccine platform including vaccines for coccidiosis management and other poultry diseases.
• COCCIVAC Poultry Coccidiosis Vaccines Poultry vaccines for coccidiosis control, available in multiple formulations including COCCIVAC-B52 and COCCIVAC-D2.
• RESFLOR GOLD Antibiotic and anti-inflammatory combination (florfenicol and flunixin) for treatment and control of bovine respiratory disease (BRD) in cattle.
• REVALOR Growth Implants Growth implant for cattle including REVALOR-200 (trenbolone acetate and estradiol) designed to improve feed efficiency and weight gain in beef cattle.
• CIRCUMVENT CL Swine Vaccine Vaccine for pigs 3 weeks and older providing protection against Porcine Circovirus Types 2a and 2d and Lawsonia intracellularis, with multiple dosage forms including a new 500-dose option.
• SEQUIVITY Swine Vaccines Swine vaccine platform with individual dose delivery technology for respiratory and reproductive disease prevention, including SEQUIVITY IAV-S NA for influenza A virus and SEQUIVITY ID + IDAL vaccine-device combination.
• AQUAFLOR Aquaculture Medication Aquaculture medication for fish including antibiotics, part of the aquaculture health portfolio expanded with the Elanco Aqua acquisition.
• VETSULIN Insulin product for diabetes management in dogs and cats.
• PRESTIGE Equine Vaccines Equine vaccine line including PRESTIGE Tetanus and other formulations for horse health.
• BIOMARK Aquaculture Identification Aquaculture identification and tracking technology for fish and shellfish.
• SENTINEL Companion Animal Parasiticides Parasiticides and flea/tick prevention products for companion animals including heartworm prevention, part of the broader parasiticide portfolio.

Quantifiable outcome

• 52% of U.S. veterinarians cite affordable treatment options as top unmet need in canine allergic skin disease; survey of 1,710 dog owners and 1,413 veterinarians reveals 28% of U.S. dog owners and 36% of U.S. veterinarians switched therapies in the past year.
• +5 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature7 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• TARGANcoreStrategic or Co-development Partner · 11 June 2026Merck Animal Health signed a definitive agreement to acquire TARGAN, a privately held poultry biodevice innovator headquartered in Raleigh, NC. The acquisition includes WingScan vision-based chick sorting technology processing 160,000 chicks per hour and high-speed precision ocular spray vaccine delivery. Merck has been a major shareholder in TARGAN since 2017. Transaction expected to close Q3 2026 pending regulatory approvals.
• Rejuvenate BiocoreStrategic or Co-development Partner · 8 June 2026Rejuvenate Bio, a biotechnology company spun out from Harvard Medical School's Dr. George Church laboratory, closed a $6 million financing round and entered a strategic R&D collaboration with Merck Animal Health to advance gene therapy programs targeting chronic and age-related diseases in companion animals. The collaboration leverages Rejuvenate Bio's gene therapy platform with Merck Animal Health's global commercial infrastructure and scientific expertise. Financing led by VCapital with participation from Merck Animal Health, Connecticut Innovations, Digitalis, and Kendall Capital Partners.
• SalesforcecoreTechnology or Integration · 6 May 2026Merck Animal Health selected Salesforce's Agentforce Life Sciences platform as its unified 'OneCRM' system to create 360-degree customer engagement experiences for veterinarians, pet owners, and production animal farmers. The platform consolidates data from production monitoring devices, pet microchips, automatic feeders, and prescription history to enable self-service, intelligent sales, and personalized marketing across all channels.
• Zoetis and Purina Pro Plan Veterinary Diets (Diabetes PetCare Alliance)minorGTM or Marketing Partner · 1 September 2025Merck Animal Health partnered with Zoetis and Purina Pro Plan Veterinary Diets in the Diabetes PetCare Alliance established in September 2025 to support early diabetes management in pets, combining expertise from diabetes care, nutritional therapy, and veterinary pharmaceuticals.
• Vence (Subsidiary)coreTechnology or Integration · 1 April 2025Vence, a subsidiary of Merck Animal Health, offers a GPS-enabled virtual fencing system for cattle management deployed in the US, Australia, and pilot programs in New Zealand and Canada. The system uses collars with GPS chips and sensors linked to cloud-based software for cattle movement control, labor reduction, and grazing management.
• Oklahoma State University Beef Center of ExcellenceminorStrategic or Co-development PartnerOklahoma State University launched the Beef Center of Excellence, a cross-disciplinary initiative backed by an advisory board with charter members including Merck Animal Health. The center will fund research and outreach to support an industry contributing over $3 billion annually to Oklahoma's economy, with endowed chairs in AI, beef cattle economics, and rangeland management.
• University of Nebraska-Lincoln Klosterman Feedlot Innovation CenterminorStrategic or Co-development PartnerMerck Animal Health donated $20,000 to the University of Nebraska-Lincoln Klosterman Feedlot Innovation Center to advance sustainability-focused research for feedlot cattle. This supports research partnerships with the academic institution focused on feedlot health, technology, and sustainability.
• Felton Angus Ranch (Montana)minorStrategic or Co-development PartnerFelton Angus Ranch partnered with Merck Animal Health to deploy Vence virtual fencing technology, using GPS-enabled collars for cattle movement management without traditional fencing. The ranch is part of Montana's 28 ranches now using Vence technology, with Montana Governor Greg Gianforte highlighting the innovation at the ranch.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Virbac: France-based global animal health company with parallel product coverage in parasiticides, vaccines, and specialty pharmaceuticals for companion and food-producing animals. Comparable mid-large peer.
• Elanco Animal Health: Publicly traded pure-play animal health company (~$4.7B revenue in 2025) competing across livestock and companion animals. Merck acquired Elanco's aqua business for $1.3B in February 2024, illustrating direct portfolio overlap.
• Vetoquinol: Independent French veterinary pharmaceutical group with comparable companion-animal and livestock product portfolios, competing across the same European and emerging-market channels as Merck Animal Health (MSD Animal Health).
• Zoetis: The largest pure-play animal health company globally and the most direct competitor to Merck Animal Health across vaccines, parasiticides, anti-infectives, and diagnostics. Named alongside Merck as a key player in the $89.45B animal health market.
• Ceva Santé Animale: Privately held global animal health group headquartered in France, with significant poultry, swine, and companion-animal vaccine/pharmaceutical portfolios that directly overlap Merck's INNOVAX, CIRCUMVENT, and SEQUIVITY lines.
• Dechra Pharmaceuticals: Specialty veterinary pharmaceuticals company (acquired by EQT) focused on companion-animal endocrinology, dermatology, and critical care — direct overlap with Merck's VETSULIN (insulin) and Numelvi (allergic dermatitis) franchises.
• Phibro Animal Health: Publicly traded animal health and nutrition company competing with Merck in livestock parasiticides, anti-infectives, and nutritional specialty products across cattle, poultry, and swine.
• Boehringer Ingelheim Animal Health: Animal health division of Boehringer Ingelheim, a top-3 global player with a comparable portfolio across livestock and companion-animal vaccines, parasiticides, and therapeutics. Directly competes with Merck on swine, cattle, and pet portfolios.

Broad incumbents

• IDEXX Laboratories: Dominant veterinary diagnostics and practice-management software company. Complementary rather than head-to-head with Merck Animal Health, but competes for the same veterinarian-customer wallet and is increasingly embedding in clinical workflows Merck's SenseHub targets.
• Covetrus: Largest North American animal-health distributor and a key Merck channel partner; also offers practice-management software and select pharmaceuticals, creating both a channel relationship and partial competitive overlap.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/merckah
• YouTubeyoutube.com/user/MerckAnimalHealth
• Facebookfacebook.com/merckanimalhealth
• LinkedInlinkedin.com/company/merck-animal-health

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A9 records

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Merck Animal Health